Vitae secures $15M in debt financing to support progress of discovery pipeline
This article was originally published in Scrip
Executive Summary
Vitae Pharmaceuticals, a privately held clinical-stage biopharmaceutical company, has secured a $15 million senior credit facility from Oxford Finance LLC and Silicon Valley Bank to support the progress of its discovery pipeline.